| Q90447976 | Clinical and oncological outcomes of robot-assisted radical prostatectomy with nerve sparing vs. non-nerve sparing for high-risk prostate cancer cases |
| Q37689256 | Contemporaneous comparison of open vs minimally-invasive radical prostatectomy for high-risk prostate cancer |
| Q51826519 | Delayed prostate-specific antigen recurrence after radical prostatectomy: how to identify and what are their clinical outcomes? |
| Q37607190 | Evolution of robot-assisted radical prostatectomy |
| Q46863151 | Impact of disease burden on cryoablation prostate-specific antigen outcomes |
| Q45047233 | Inverse stage migration in patients undergoing radical prostatectomy: results of 8916 European patients treated within the last decade |
| Q37527811 | Lymph node dissection during robot-assisted radical prostatectomy: where do we stand? |
| Q34617238 | Nerve-sparing robotic prostatectomy in preoperatively high-risk patients is safe and efficacious |
| Q43089360 | Oncologic outcomes following radical prostatectomy in the active surveillance era. |
| Q41212964 | Patients with prostate cancer after radical prostatectomy: Stage migration and changes in tumor characteristics from 1998-2012 |
| Q46604306 | Predicting non-organ-confined prostate cancer in men diagnosed after 2000. |
| Q44525934 | Predictors for positive surgical margins after robot-assisted radical prostatectomy: a single surgeon's series in Japan. |
| Q36748537 | Robotic radical prostatectomy in high-risk prostate cancer: current perspectives |
| Q37956334 | Robotic-assisted laparoscopic prostatectomy for high-risk prostate cancer: technical considerations and review of the literature |
| Q42429784 | Role of Surgery in High-Risk Localized Prostate Cancer |
| Q34453371 | Role of robot-assisted radical prostatectomy in the management of high-risk prostate cancer |
| Q39583603 | Safety of selective nerve sparing in high risk prostate cancer during robot-assisted radical prostatectomy. |